• 2019 Senior Report Senior Report: Older Americans have more options for home care, but still struggling.

    The United Health Foundation has released results of a sweeping new study benchmarking the health of older adults. The America's Health Rankings® Senior Report was created in partnership with GAPNA to improve the health of America's seniors.

    The data will help advanced practice nurses and other providers deliver quality care.

    Find out about it!

  • FREE continuing education credit is available for the following session:

    "Decisional Capacity"

    (session captured at the GAPNA 2018 Annual Conference)

    For July/August 2019 - Get Your Free CNE Now!

  • Save $90 - Register Now with Early Bird Savings!
    38th Annual GAPNA Conference

    October 3-5, 2019 at the Paris Hotel, Las Vegas, NV.

    Focused education; lasting connections, networking, free access to the GAPNA Online Library.

    Earn up to 22 contact hours (including pre-conference workshops).

    Get more information and register now!

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

Medicare Part D Coverage Gap Reduces Antidepressant Use in the Elderly

The Medicare Part D prescription drug benefit includes a $265 deductible, an insured period during which the beneficiary pays 25%of drug costs from $265 to $2,400, and a coverage gap when the beneficiary pays 100 percent of drug costs until reaching the catastrophic limit of $3,850; then they pay 5%.

A new study found elderly Medicare patients with depression enrolled in stand-alone Part D plans in 2007 reduced their use of antidepressants during the Medicare Part D coverage gap.

In fact, a full gap in drug coverage resulted in a 12.1% reduction in antidepressant use, particularly for brand-name drugs.

For more info, see Zhang, Y. et al. (2012). Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression. Archives of General Psychiatry, 69(7), 672-679.

Related Topic 1: 

GAPNA Newsletter Issue: